Andere Sprachen Nightingale Health Oyj

Aktien

A2QR4M

FI4000490875

HEALTH

Biotechnologie

Markt geschlossen - Nasdaq Helsinki Andere Börsenplätze 18:00:00 13.06.2025			% 5 Tage	% 1. Jan.
2,535 ^EUR	-2,12 %		-6,11 %	-11,98 %

13.06.	Nightingale Health Oyj kündigt Veränderungen im Führungsteam an	CI
02.05.	Nightingale Health Oyj gibt Änderungen in der Geschäftsführung mit Wirkung zum 2. Mai 2025 bekannt	CI

Andere Sprachen

Nightingale Health Oyj Announces Executive Changes	13.06.
Nightingale Health strengthens its commercial operations with new EMEA appointment	13.06.
Nightingale Health Oyj : management team members Minja Salmio and Satu Saksman recognized for outstanding leadership	12.06.
Nightingale Health’s management team members Minja Salmio and Satu Saksman recognized for outstanding leadership	12.06.
Nightingale Health Oyj : Board of Directors resolved on new stock option program	09.06.
Nightingale Health’s Board of Directors resolved on new stock option program	09.06.
Nightingale Health Oyj : Changes in Nightingale Health Plc's Management Team	02.05.
Changes in Nightingale Health Plc’s Management Team	02.05.
Nightingale Health Oyj Announces Management Changes, Effective May 2, 2025	02.05.
Nightingale Health Oyj : Conversion of Nightingale Health Plc's Series A shares to Series B shares	23.04.
Conversion of Nightingale Health Plc’s Series A shares to Series B shares	23.04.
Nightingale Health to Launch US Laboratory in Summer	10.04.
Nightingale Health To Open U.S. Lab For Medical Research In Summer 2025	10.04.
Nightingale Health Oyj : laboratory implementation in the United States progresses as planned - opens first to medical research customers in Summer 2025	10.04.
Nightingale Health’s laboratory implementation in the United States progresses as planned – opens first to medical research customers in Summer 2025	10.04.
Trading in Nightingale Health's B shares and ADRs begins on 21 March 2025 on the OTCQX International Market in the US	21.03.
OTC Markets Group Welcomes NIGHTINGALE HEALTH OYJ to OTCQX	21.03.
Nightingale Health Oyj(HLSE:HEALTH) added to OMX Nordic Small Cap Index	20.03.
Nightingale Health Oyj(HLSE:HEALTH) added to OMX Nordic All-Share Index	20.03.
Nightingale Health to Start Trading on Nasdaq Helsinki's Main Market	18.03.
Nightingale Health Plc's listing application has been approved and trading in its Series B shares on the Main Market of Nasdaq Helsinki will commence on 19 March 2025	18.03.
Nightingale Health Applies for Listing on OTCQX International Market in US	17.03.
The Finnish Financial Supervisory Authority has approved Nightingale Health Plc's Finnish prospectus	17.03.
Nightingale Health establishes ADR program in the US - trading in Company's B shares and ADRs begins on 19 March 2025, at the earliest, and 24 March 2025, at the latest, on the OTCQX Market in the US	17.03.
Nightingale Health Seeks Listing Transfer of B Shares to Nasdaq Helsinki	12.03.

Keine Ergebnisse zu dieser Suche

Mehr Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Nightingale Health Oyj

Aktien

A2QR4M

FI4000490875

HEALTH

Biotechnologie

Andere Sprachen

Filter